According to a study presented at the American University of Rheumatologys annual conference.

Breast cancer patients more likely to possess joint pain from taking AIs: Study Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors if indeed they have advanced stage malignancy, according to a study presented at the American University of Rheumatology’s annual conference, held Nov. 7-11, in Atlanta. The study is one of the first to recognize factors that raise the likelihood a patient will suffer joint pain from AI therapy. AIs, the standard adjuvant therapy for post-menopausal breast cancer, can cause joint pain in patients, in the wrists and hands mostly.Regardless of the unmet medical want, the just current treatment is certainly life-longer adherence to a gluten-free diet, which is incredibly difficult to maintain. Research results display that actually up to 50 percent of individuals on a gluten-free diet plan remain symptomatic and that little intestinal mucosal damage persists despite efforts to adhere to the dietary plan. Dr. Kinneret Savitsky, CEO of BioLineRx, stated BL-7010 is definitely a significant chance for us, taking into consideration there are no accepted remedies for celiac disease and there have become few clinical-stage projects world-wide currently being developed because of this disease. We anticipate commencing the Phase 1/2 safety research for BL-7010 by the finish of the year, accompanied by an efficacy research, which we desire to commence in the next half of 2014.